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Abstract
Background: Participation in bowel scope screening (BSS) is low (43%), limiting its potential to reduce colorectal
cancer (CRC) incidence and mortality. This study aimed to quantify the prevalence of barriers to BSS and examine
the extent to which these barriers differed according to non-participant profiles: non-responders to the BSS invitation,
active decliners of the invitation, and non-attenders of confirmed appointments.
Methods: Individuals invited for BSS between March 2013 and December 2015, across 28 General Practices in England,
were sent a questionnaire. Questions measured initial interest in BSS, engagement with the information booklet,
BSS participation, and, where applicable, reasons for BSS non-attendance. Chi-square tests of independence were
performed to examine the relationship between barriers, non-participant groups and socio-demographic variables.
Results: 1478 (45.8%) questionnaires were returned for analysis: 1230 (83.2%) attended screening, 114 (7.7%) were non-
responders to the BSS invitation, 100 (6.8%) were active decliners, and 34 (2.3%) were non-attenders. Non-responders
were less likely to have read the whole information booklet than active decliners (x2 (2, N = 157) = 7.00, p = 0.008) and
non-attenders (x2 (2, N = 101) = 8.07, p = 0.005). Non-responders also had lower initial interest in having BSS than either
active decliners (x2 (2, N = 213) = 6.07, p = 0.014) or non-attenders (x2 (2, N = 146) = 32.93, p < 0.001). Overall, anticipated
pain (33%) and embarrassment (30%) were the most commonly cited barriers to BSS participation. For non-attenders,
however, practical, appointment-related reasons were most common (27%).
Conclusions: Interventions to improve BSS uptake should be more nuanced and use targeted strategies to address the
specific needs of each group.
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Background
Colorectal cancer (CRC) is the second most common
cause of cancer-related deaths in the UK [1], making
prevention and early diagnosis a priority in cancer
control. Results from the UK Flexible Sigmoidoscopy
(FS) Trial showed that a single FS examination with
removal of pre-malignant growths reduced CRC mor-
tality by 43% and CRC incidence by a third [2]. In
response to these results, and other worldwide re-
search supporting FS as a screening modality [3, 4],
NHS England now offer men and women a single, free
FS screen at age 55 as part of the NHS Bowel Cancer
Screening Programme. This is known as ‘bowel scope
screening’ (BSS) and was introduced in March 2013. A
recent follow-up of the UK trial has shown that the
benefits of a FS screen are retained 17 years after the
initial examination [5], providing further evidence as
to the need to increase uptake of the test. Uptake
among the screening-eligible population will be key to
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realizing the projected public health benefits of this
screening test [6].
A recent study analysing BSS invitations sent within
the first 14 months of BSS roll out in England
(21,187 invitations) found that only 43% of those
invited attended their pre-booked appointment [7].
Furthermore, people from more socioeconomically de-
prived and ethnically diverse backgrounds were sig-
nificantly less likely to take part and, in contrast to
CRC screening using the home-based guaiac faecal
occult blood test (gFOBt), women were significantly
less likely to attend BSS than men (42% vs. 45%) [7].
For women, this highlights an almost twofold gap be-
tween participation in BSS and both breast and cer-
vical screening [8, 9].
A recent qualitative study conducted with BSS invi-
tees identified a number of practical and psycho-
logical barriers to attendance, and concluded that it
was not the presence of concerns about the test but
rather the strength of these concerns that was most
important in making the decision to participate [10].
While important and informative, previous research
into the barriers and facilitators of screening uptake
has commonly considered non-participants as a single
group; however, there is evidence to suggest that
there are distinct sub-groups of non-participants. For
example, in the UK FS trial, those who never
returned the pre-trial questionnaire were less likely to
remember receiving invitation materials and more
likely to report procrastination than those who made
an active decision not to participate [11]. Furthermore, a
quantitative analysis of data from the UK FS trial demon-
strated that non-intenders, non-attenders and attenders
all had unique demographic and psychological profiles.
Non-attenders were the most difficult group to character-
ise, with only 50% correctly classified by discriminant ana-
lyses [12]. A more nuanced understanding of non-
participants is particularly important in trying to better
understand to what extent decisions about cancer screen-
ing are based on well-informed choices. Previous research
has identified distinct types of non-attenders within the
context of breast cancer screening, and demonstrated
among other socioeconomic and psychological differ-
ences that passive non-participants are more likely to
come from socioeconomically deprived background
than active non-participants [13, 14]. In a more a re-
cent study, Marlow and colleagues highlighted that
within non-participants of cervical screening, a major-
ity had not made an active decision to not participate
but rather lacked awareness or the means to translate
their intention to attend into action [15].
In the context of the BSS, non-participants can be
classified into three major groups: those who never re-
spond to the invitation (non-responders, NRs), those
who, following the receipt of the invitation or the re-
minder letter, choose to initiate contact with the
screening centre in order to decline the offer (active
decliners, ADs), and those who initially confirm but
subsequently fail to attend their appointment (non-at-
tenders, NAs). Understanding differences across these
major groups of screening non-participants will help
focus future research to address the concerns specific
to each group. The aim of this study was to quantify
the prevalence and combination of barriers to BSS and
investigate the extent to which barriers vary across the
different types of non-participants.
Methods
Sample population
Between May and October 2015, 28 General Practices
located across Surrey, London, Norfolk, Tyne and
Wear, and Wolverhampton were recruited to this
study. Questionnaires were sent to registered patients
within each practice who had received their BSS invi-
tation within the last 2 years. Age was used as a
proxy for this eligibility criteria; patients who were
aged between 55 (+ 2 months) and 57 (+ 0 months)
years were invited to participate. Individuals noted as
not being able to read English were identified within
each practice and excluded from the invitation
process.
Data collection
Each eligible individual was assigned a unique study
ID number. The name, address and study ID number
of each person was then sent to Docmail, an online
hybrid mailing company, for the delivery of study
packs. Each study pack contained a cover letter from
the individual’s GP, an 8-page questionnaire booklet,
and a freepost return envelope (addressed to Univer-
sity College London, UCL). The cover letter included
an introduction to the study and instructions on how
to participate, encouraging the return of the ques-
tionnaire (completed or not) within 2 weeks to avoid
a reminder. Survey respondents were informed that
by returning a completed questionnaire they were
providing consent for their data to be used in this
study.
All 28 practices sent a reminder to those who
failed to return their questionnaire after an average
of 4 weeks and included a replication of the original
study pack. All but one practice sent a second re-
minder, containing a letter only, to those who had
not returned a questionnaire after a further 4 weeks
(on average). A unique study ID number was at-
tached to each questionnaire and was used to
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identify those requiring a reminder; questionnaires
were anonymous.
Measures
For this study we focused our analysis on a selection
of questions within the questionnaire that were rele-
vant to our current research aim.
Demographic characteristics
Survey respondents were asked to select their re-
sponse for gender (Male; Female), living arrangement
(Single; Married; Cohabiting/ living with partner;
Divorced/ separated; Widowed), ethnicity (White;
Other), employment status (Employed full-time;
Employed part-time; Unemployed; Full-time home-
maker; Retired; Student; Disabled or too ill to work;
Self-employed) and self-rated health (Excellent; Good;
Fair; Poor). Age (in years) was requested as an open
response.
Socioeconomic deprivation
An additional three demographic questions were asked
in order to calculate a proxy measure for socioeco-
nomic deprivation. One point was given to an individ-
ual if their household did not have a car or van, if they
had no formal qualifications and if they did not own
their own home [16, 17]. Scores, therefore, ranged
from 0 to 3, with high scores indicating higher levels
of social deprivation.
Index of multiple deprivation
To compare the socioeconomic status of responders
and non-responders, practices provided a score on
the Index of Multiple Deprivation (IMD) [18] for each
patient they had invited. IMD is an area-based meas-
ure of deprivation based on income, employment,
health and disability, education, skills and training,
barriers to housing and services, crime and living en-
vironment, and can be identified from a postcode
[18]. IMD scores are divided into quintiles, with quin-
tiles 1 to 5 representing the least to the most de-
prived areas.
Interest in BSS
Participants who indicated they had received an ap-
pointment letter for BSS were asked: “When you re-
ceived the appointment letter, how interested were you
in having the bowel scope screening test?” Response
options were: “Very”, “Moderately”, “Slightly”, and
“Not at all”.
Engagement
The extent to which survey respondents were engaged
with the information booklet sent with the BSS invi-
tation was measured by asking: “How much of the in-
formation booklet did you read?”. Response options
were: “None of it”, “Some of it”, “Most of it”, “All of
it” and “Don’t know”.
BSS invitation response
Survey respondents were asked “Did you respond to
your appointment letter (i.e. confirm or cancel)?”, with
the following response options: “Yes, I confirmed my
appointment”, “Yes, I changed my appointment date
or time”, “Yes, I cancelled my appointment” and “No,
I did not respond”. Those who selected “No, I did not
respond”, were then asked if they had then received a
reminder letter and, if so, how they had responded to
that (response options were the same as above).
Self-reported BSS participation
To determine whether survey respondents had
attended their BSS appointment and received a BSS
test, the following question was asked: “Did you have
a bowel scope screening test?”. Response options were
“Yes” and “No”. To allow verification of BSS participa-
tion status, survey respondents were also asked at the
end of the questionnaire if they wished to give permis-
sion for the research team to contact the NHS Bowel
Cancer Screening Programme to check their response
to the BSS invitation. Those who agreed were then
asked to provide their name, date of birth and
postcode.
Barriers to BSS
Survey respondents who stated that they had not par-
ticipated in BSS were asked to indicate their reasons
for non-attendance from a pre-specified list of 15 op-
tions. Survey respondents were instructed to select all
reasons they deemed relevant to them (see Supple-
mentary data page 3). Space was additionally provided
for non-listed barriers to be added in an open text for-
mat. These were coded and included in the overall list
of barriers for analysis.
Statistical analysis
Chi-square tests of independence were performed to
examine the relationship between defined participa-
tion/non-participation groups and socio-demographic
variables (Tables 1 and 2). We used Fisher’s exact
test (two-tailed, FET) for variables that had at least
one cell with a frequency of less than 5, i.e.
‘deprivation’ and ‘interest’ (Table 2). Chi-square test
of independence and Fisher’s exact test (two tailed)
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were also used, where appropriate, to examine the
relationship between non-participation groups and
single barriers1 (Tables 3 and 4). Where a test indi-
cated a significant relationship, we conducted further
pair-wise comparisons using Bonferroni adjusted
alpha levels for the number of potential comparisons
per variable (i.e. 0.05/3 = 0.016). We used Stata/IC
version 14.1 (StataCorp LP, College Station, TX) to
conduct the data analysis and only report significant
results.
Table 1 Descriptive statistics of the overall study sample (row percentages)a
Participants
(N = 1079)
Non-participants
(N = 243)
p-value*
N (%) N (%)
Age
55 years 254 (23.54) 53 (21.81) 0.385
56 years 667 (61.82) 146 (60.08)
57 years 158 (14.64) 44 (18.11)
Gender
Male 528 (48.93) 103 (42.39) 0.065
Female 551 (51.07) 140 (57.61)
Ethnicity
Other 75 (6.97) 27 (11.20) 0.026
White 1001 (93.03) 214 (88.80)
Living arrangement
Married or living with partner 860 (79.85) 179 (73.97) 0.043
Single, divorced or widowed 217 (20.15) 63 (26.03)
Markers of socioeconomic deprivation
markers 845 (78.97) 170 (70.54) < 0.001
1 marker 171 (15.98) 42 (17.43)
2–3 markers 54 (5.05) 29 (12.03)
Index of Multiple Deprivation IMD
1st quintile (least deprived) 401 (37.72) 80 (33.76) 0.239
2nd quintile 262 (24.65) 53 (22.36)
3rd quintile 177 (16.65) 40 (16.88)
4rd quintile 130 (12.23) 33 (13.92)
5th quintile (most deprived) 93 (8.75) 31 (13.08)
Paid employment
No 172 (16.09) 61 (25.31) 0.001
Yes 897 (83.91) 180 (74.69)
Self-rated health
Excellent, good 932 (86.46) 179 (73.97) < 0.001
Fair, poor 146 (13.54) 63 (26.03)
Initial interest in Bowel Scope
Very, moderately 1022 (95.13) 123 (51.04) < 0.001
Slightly, not at all 52 (4.87) 118 (48.96)
Extend to which book was read
None, some or most 252 (28.00) 78 (44.32) < 0.001
All of it 648 (72.00) 98 (55.68)
Note that missing cases are not reported, so that the column frequencies do not always sum up to the total stated at the top of the table
aOnly eligible sample (i.e. aged between 55 and 57 years)
*The p-values are derived from Chi-square tests of Independence
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Results
Questionnaire response rate
The study questionnaire was sent to 3226 eligible indi-
viduals with 1478 (45.8%) completed questionnaires
returned. A further 292 (9.1%) were returned blank.
Using study ID numbers and data available in GP
records, selected comparisons, i.e. gender and area
level deprivation (using postcodes converted to Index
of Multiple Deprivation scores), could be made be-
tween those who returned a completed questionnaire,
those who returned a blank questionnaire (indicating they
did not want to respond to the survey) and those who did
Table 2 Predictors of screening participation (complete case analysis for both unadjusted and adjusted models, N = 1036)
(%) Unadjusted Adjusted
Odds ratio 95% CI Odds ratio 95% CI
Age
55 years 82.9% Ref Ref.
56 years 84.4% 1.121 0.760–1.656 1.072 0.667–1.721
57 years 82.0% 0.941 0.555–1.596 0.836 0.443–1.577
Gender
Male 86.0% Ref Ref.
Female 81.7% 0.729 0.522–1.019 0.770 0.512–1.157
Ethnicity
Other 74.0% Ref Ref.
White 84.5% 1.910 1.115–3.272* 1.065 0.524–2.162
Living arrangement
Married/living with somebody 85.0% Ref Ref.
Single/div./wind. 78.8% 0.657 0.450–0.959* 0.752 0.463–1.222
Index of Multiple Deprivation IMD
1st quintile 85.2% Ref Ref.
2nd quintile 85.0% 0.980 0.629–1.526 1.005 0.593–1.700
3rd quintile 84.0% 0.911 0.554–1.497 0.935 0.513–1.706
4rd quintile 80.0% 0.693 0.412–1.164 0.807 0.419–1.555
5th quintile 78.4% 0.627 0.359–1.095 1.082 0.518–2.259
Markers of socioeconomic deprivation
0 markers 85.1% Ref Ref.
1 marker 83.0% 0.858 0.547–1.346 1.416 0.796–2.517
2–3 markers 67.2% 0.359 0.204–0.635** 0.807 0.371–1.755
Paid employment
No 76.5% Ref Ref.
Yes 85.3% 1.785 1.211–2.629** 1.407 0.856–2.311
Self-reported health
Excellent/good 69.8% Ref Ref.
Fair/poor 86.3% 2.728 1.853–4.016** 2.306 1.410–3.770**
Initial interest in Bowel Scope
Very/moderately 30.3% Ref Ref.
Slightly/not at all 90.8% 22.727 14.542–35.519** 22.292 13.768–36.094**
Extend to which booklet was read
None/some of it 76.5%
All of it 86.8% 2.027 1.445–2.842** 1.136 0.737–1.751
N 1036 1036
* p < 0.05; ** p < 0.01
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not respond at all. Women were found to be significantly
more likely to answer the questionnaire than men (48.1%
vs 43.5%, x2 (1, N = 3226) = 6.78, p = 0.009). Furthermore,
responders to the questionnaire were more likely to live in
a less deprived area (x2 (4, N = 2915) = 13.30, p < 0.001).
Among those who returned a completed question-
naire, 38 (2.6%) were removed from the analysis due
to stated age being older or younger than expected
for the study sample. Of the questionnaire respon-
dents included in the final analysis (n = 1440), the
Table 3 Descriptive statistics of the three non-participant groups (column percentages)a
NRs
(N = 110)
ADs
(N = 99)
NAs
(N = 34)
p-value*
N (%) N (%) N (%)
Age
55 years 28 (25.45) 19 (19.19) 6 (17.65) 0.666
56 years 61 (55.45) 64 (64.65) 21 (61.76)
57 years 21 (19.10) 16 (16.16) 7 (20.59)
Gender
Male 57 (51.82) 34 (34.34) 12 (35.29) 0.026
Female 53 (48.18) 65 (65.66) 22 (64.71)
Ethnicity
Other 10 (9.17) 11 (11.22) 6 (17.65) 0.393
White 99 (90.83) 87 (88.78) 28 (82.35)
Living arrangement
Married or living with partner 76 (69.72) 78 (78.79) 25 (73.53) 0.330
Single, divorced or widowed 33 (30.28) 21 (21.21) 9 (26.47)
Markers of socioeconomic deprivation
0 markers 62 (56.88) 82 (83.67) 26 (76.47) 0.001a
1 marker 26 (23.85) 11 (11.22) 5 (14.71)
2–3 markers 21 (19.27) 5 (5.10) 3 (8.82)
Paid employment
No 26 (23.85) 22 (22.45) 13 (38.24) 0.169
Yes 83 (76.15) 76 (77.55) 21 (61.76)
Self-rated health
Excellent, good 81 (74.31) 71 (71.72) 27 (79.41) 0.674
Fair, poor 28 (25.69) 28 (28.28) 7 (20.59)
Initial interest in Bowel Scope
Very, moderately 39 (35.78) 53 (53.54) 31 (93.94) < 0.001a
Slightly, not at all 70 (64.22) 46 (46.46) 2 (6.06)
Extent to which book was read
None, some or most 45 (59.21) 28 (35.90) 5 (22.73) 0.001
All of it 31 (40.79) 50 (64.10) 17 (77.27)
NRs Non Responders, ADs Active Decliners, NAs Non-Attenders
aOnly eligible sample who did not attend the screening (i.e. aged between 55 and 57 years)
*The p-values are derived from Chi-square tests of Independence, except for ‘markers of socioeconomic deprivation’ and ‘initial interest in bowel scope’ which
were both assessed with Fisher’s exact testa
Table 4 Number of reasons for not participating stated by non-
attenders
Total
(N = 243)
NRs
(N = 110)
ADs
(N = 99)
NAs
(N = 34)
p-value*
N (%) N (%) N (%) N (%)
None 34 (13.99) 8 (7.27) 22 (22.22) 4 (11.76) 0.002
One 89 (36.63) 36 (32.73) 34 (34.34) 19 (55.88)
Two or
more
120 (49.38) 66 (60.00) 43 (43.43) 11 (32.35)
NRs Non Responders, ADs Active Decliners, NAs Non-Attenders
*The p-value is derived from Fisher’s exact test
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majority were female (52.9%), married or cohabiting
(78.2%), white (91.6%), and living in areas with the
lowest levels of deprivation (38.8%). Figure 1 shows
the flow of survey respondents through the study.
BSS attendance
Variation in socio-demographic variables by BSS
attendance status
Table 1 presents a summary of demographic variables
by participation. Due to small sample size, response
options were combined for some variables. Among
those who returned a completed questionnaire, 1079
(81.62%) confirmed and attended their BSS appoint-
ment, and 243 (18.38%) did not. Among those who
gave us permission, there was 90.8% correspondence
between self-reported and verified participation status.
BSS non-participants were more likely to be from
ethnically diverse backgrounds (x2 (2, N = 1317) = 4.94,
p = 0.026), not living with a partner (x2 (2, N = 1319) =
4.09, p = 0.043), more deprived (x2 (2, N = 1311) = 8.00,
p = 0.005), and in paid employment (x2 (2, N = 1310) =
11.44, p = 0.001). Similarly, those who did not partici-
pate in BSS were more likely to report a poor health
status (x2 (2, N = 1320) = 23.13, p < 0.001), and low ini-
tial interest in having the BSS test (x2 (2, N = 1315) =
340.39, p < 0.001). Relatedly, BSS non-participants were
also less likely to have read the whole information
booklet (x2 (2, N = 1076) = 18.44, p < 0.001). A multivar-
iable regression (see Table 2) demonstrated that only
self-reported health and initial interest in bowel scope
remained significant predictors of BSS attendance.
Variation in socio-demographic variables by non-
participant subgroups
Of the 243 BSS non-participants, 110 did not respond
to their BSS invitation (NRs; 45.3%), 99 actively de-
clined their BSS invitation (ADs; 40.7%) and 34 con-
firmed their BSS appointment but subsequently failed
to attend (NAs; 14.0%). Table 3 displays the socio-
demographic variables for the three different types of
non-participation. Chi-square tests of independence
showed that the three types of non-participation dif-
fered in their gender composition and engagement
with the information booklet (p < 0.05). Fisher’s exact
test showed that initial interest in screening and socio-
economic deprivation also significantly varied across
the three groups (p < 0.05, FET).
Pairwise comparisons, using a Bonferroni corrected
significance level (p < 0.016), revealed that compared
to ADs, NRs were more likely to be male (x2 (2, N
= 209) = 6.47, p = 0.011) and be more deprived (p <
0.001, FET). NRs were less likely to have read the
Questionnaires sent out by mail 
(N=3,226)
Not returned (N=1,452; 45%)
Returned questionnaire 
(N=1,770; 55%)
Returned empty (N=292; 
16.5%)
Filled out the questionnaire 
(N=1,478; 83.5%)
Age missing or not in the 
eligible rage of 55 till 57 (N=38; 
2.6%)
Aged between 55 and 57 years 
(N=1,440; 97.4%)
Permission not given (N=208; 
14.4%)
Permission given (N=1.232; 
85.6%)
Could not be verified (N=344; 
27.9%)
Could be verified (N=888; 
72.1%)
Self-reported participation 
(N=768; 86.5%) 
Self-reported non-participation 
(N=120; 13.5%)
Self-stated behaviour matches 
records of screening centre
(N=759; 98.8%)
Self-stated behaviour matches 
records of screening centre 
(N=109; 90.8%)
Fig. 1 The flow of participants through the study
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whole booklet than ADs (x2 (2, N = 154) = 8.39, p =
0.004) or NAs (x2 (2, N = 98) = 9.09, p = 0.003). Simi-
larly, NRs stated significantly lower initial interest in
having the BSS test than either ADs (x2 (2, N = 208) =
6.63, p = 0.010) or NAs (p < 0.001, FET). While there
was no difference between ADs and NAs with regard
to their level of engagement, ADs indicated signifi-
cantly lower levels of initial interest in BSS (p < 0.001,
FET).
Barriers
Number of barriers
209 (86%) BSS non-participants gave at least one reason
for not participating in BSS: NRs = 102 (93%), ADs = 77
(78%) and NAs = 30 (88%); Table 4. Those who an-
swered the question gave on average 2.12 reasons (NRs
= 2.35, ADs = 2.03 and NAs = 1.6). The number of rea-
sons endorsed varied by the type of non-participant (p
= 0.002, FET). Pairwise comparisons show that NRs
were more likely to state two or more reasons for not
participating than ADs (x2 (2, N = 209) = 10.89, p =
0.004) and NAs (p = 0.014, FET). There was no differ-
ence between ADs and NAs (p = 0.084, FET).
Barriers by subgroup
Table 5 shows the list of barriers and the proportion
of the three non-participant groups endorsing them
(the two items on the enema were combined). Worry-
ing the test would be painful (33.01%), embarrassing
(30.14%) and simply not personally needed (25.84%)
were the three most commonly endorsed barriers
overall. One interesting result was that NAs had a
lower rate of “not needed” and a higher rate of “other
test done”, While these two items could have been re-
ferring to a related issue. However, Appendices 1 and
2 show that none of our respondents ever endorsed
both items together.
Combination of barriers
Pain and embarrassment was the most frequent com-
bination of barriers to BSS (33.33%), followed by em-
barrassment and the enema (23.33%), and thirdly the
combination of pain and worry about harm to the
bowel (20.00%); (see Appendices 1 and 2 for details).
Discussion
This study aimed to identify the demographic profile
of BSS participants and non-participants, and import-
antly to compare profiles and reasons for BSS
non-participation across three distinct subgroups of
non-participants: those who do not respond to the
screening invitation (NRs), those who actively decline
the invitation (ADs) and those who confirm their ap-
pointment but then do not attend (NAs).
This is the largest study of self-reported participation
in BSS to date, and the first to consider sub-groups of
non-participants. In our study, as expected, the major-
ity of questionnaire respondents had participated in
Table 5 Stated reasons for not participating across the three non-participant groups (N = 209)
Total
(N = 209)
NRs
(N = 102)
ADs
(N = 77)
NAs
(N = 30)
p-value*
N % N % N % N %
Worried about pain 69 (33.01) 38 (37.25) 25 (32.47) 6 (20.00) 0.208b
Embarrassing 63 (30.14) 39 (38.24) 22 (28.57) 2 (6.67) 0.002
Not needed 54 (25.84) 31 (30.39) 22 (28.57) 1 (3.33) 0.004
Worried about harm 53 (25.36) 23 (22.55) 25 (32.47) 5 (16.67) 0.159b
Appointment problems 51 (24.40) 24 (23.53) 19 (24.68) 8 (26.67) 0.938b
Enema not wanted 44 (21.05) 24 (23.53) 14 (18.18) 6 (20.00) 0.678b
No time 34 (16.27) 20 (19.61) 10 (12.99) 4 (13.33) 0.469
Worried about result 16 (7.66) 15 (14.71) 0 (0.00) 1 (3.33) < 0.001
Medical reasons 16 (7.66) 4 (3.92) 5 (6.49) 7 (23.33) 0.005
Unacceptable 12 (5.74) 7 (6.86) 5 (6.49) 0 (0.00) 0.428
Bad experience 11 (5.26) 6 (5.88) 3 (3.90) 2 (6.67) 0.760
Other test donea 11 (5.26) 2 (1.96) 5 (6.49) 4 (13.33) 0.030
Forgot 7 (3.35) 6 (5.88) 0 (0.00) 1 (3.33) 0.070
Financiala problems 3 (1.44) 1 (0.98) 1 (1.30) 1 (3.33) 0.537
NRs Non Responders, ADs Active Decliners, NAs Non-Attenders
The provided options ‘Not understanding the information booklet’ and ‘transport problems’ were not selected by anyone in either of the three groups
aEmerged from free text section
*The p-values are derived from Fisher’s exact test if not otherwise stated (bChi-square test of Independence)
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BSS. However, within the non-participant group, vari-
ation allowed sub-group comparisons to be made; the
majority were NRs, followed by ADs and then NAs.
Compared to BSS participants, non-participants as a
whole were more likely to be female, not married or liv-
ing in a relationship, in paid employment, and from
more socio-economically deprived backgrounds. These
results closely match those described in a recent ana-
lysis of participation in the first 14 months of BSS
roll-out [7]. Additionally, non-participants were less
likely to state that they were interested in having the
test when they first received the invitation and to
have read the information leaflet that was sent as part
of the invitation. This highlights a need to find other
ways to engage invitees with the BSS opportunity.
We found important differences between the three
sub-groups in their demographic profile and reported
barriers to BSS participation. Specifically, NAs noted
fewer barriers, and were more likely to report higher
initial interest in having the BSS test, than the other
two groups. The most frequently barriers reported by
NAs focused on more practical elements of attendance
(e.g. appointment problems and medical reasons), sug-
gesting that this sub-group of non-participants may
have had higher intentions to have the BSS test but
that practical reasons prevented them from actually
attending their appointment. This supports recent ob-
servations in non-attenders for diagnostic colonoscopy
in the NHS Bowel Cancer Screening Programme [19].
In comparison, NRs and ADs were more likely to en-
dorse anticipated pain and embarrassment as reasons
for not participating in BSS, which suggests that these
emotional barriers may have influenced the low initial
interest in having the BSS test among these two
sub-groups of non-participants.
Several of the barriers reported in this study have
also been described in previous qualitative studies.
The perceived lack of need has also been identified
by Hall and colleagues [10], as part of their interview
study of screeners and non-screeners; while, McCaff-
ery and colleagues [11] also reported that perceived
lack of susceptibility and lack of symptoms were im-
portant factors in the decision to decline screening.
However, unlike the findings by McCaffery and col-
leagues [11] that suggested procedural barriers, such
as anticipated embarrassment and pain and discom-
fort, to be reported as minor factors in the decision
to decline, our study found these barriers to be much
more prominent than previously reported.
The findings by Hall and colleagues [10] suggest
that both BSS participants and non-participants antic-
ipated the screening procedure to be unpleasant and
invasive, and this often led to strong emotional re-
sponses to the invitation materials. In our study,
perceiving the procedure to not be important but
time consuming and embarrassing was prominent
among those who did not read all the information
materials. It is possible that with increasing awareness
of the existing Bowel Cancer Screening Programme
using gFOBt, and knowing that this test offers a
much less invasive alternative at the age of 60, people
might be more likely to question the invasive nature
of BSS. Uptake of BSS might benefit from a better
distinction between the two aspects of the
programme, with bowel scope aiming to prevent CRC
and the current gFOBt test being squarely aimed at
detecting CRC early.
Distinguishing between different groups of BSS
non-participants enables screening programme man-
agers, practitioners, and policy makers to identify dif-
ferent barriers for different subgroups and develop
more targeted interventions. Such interventions could
include the use of narratives from previous partici-
pants, or reference to data showing that a vast major-
ity of people who had the test report positive
experiences. Similarly, previous research has identified
that offering same-sex practitioners is a popular op-
tion, particularly among women who previously did
not respond to the test invitation, and may be an im-
portant factor in helping to reduce anticipated embar-
rassment [20, 21]. A more proactive approach to
informing invitees about the intensity of pain and dis-
comfort to expect, and of ways these can be reduced,
would also be important. For example, enabling
screening invitees to choose early on whether they
prefer pain relief in the form of Entonox, and when it
is given (either in response to discomfort or
pre-emptively to avoid pain and discomfort) could be
considered.
Finally, while NAs represent a small proportion of
BSS non-participants, they should not be forgotten.
The programme has the strongest mandate to try and
help these individuals realize their intention to have
the test. For NAs, the main barriers were practical
and medical aspects and so, for this group specific-
ally, more autonomy over the appointment booking
system and reminders of the self-referral process may
be particularly important.
This study had a number of limitations. The study
was carried out in primary care which enabled us
identify eligible respondents without having to inter-
fere with the invitation process. However, it should
be acknowledged that we were limited to selecting
among practices who were located in areas in which
BSS had been rolled out. Despite our best efforts not
all practices were available to participate so our selec-
tion of 28 practices did not constitute a probabilistic
sample which may have introduced bias.
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The survey had a response rate of only 45.8%,
which is good compared with many similar CRC
screening surveys, but survey respondents were more
likely to come from affluent areas and be female
which may well have caused uptake in this study to
be significantly higher compared with what has been
reported in the programme [7]. Overall, it is import-
ant to acknowledge that compared with the general
population our sample was also more affluent and
educated. In addition, as we were unable to provide
translated versions of our questionnaires, our ability
to identify barriers specific to different ethnic groups
was limited.
Although our study analysed barriers of screening
based on self-reported uptake, the results remain
relevant as the self-reported screening behaviours
proved to be very accurate. In our questionnaire, we
asked responders to state whether they would allow
the research team to check their screening status in
their health records. While a total of 1232 re-
sponders gave permission to look up their participa-
tion records, only 888 could correctly be identified.
This discrepancy may have been the result of unclear
handwriting, as responders had to provide their
name, date of birth and postcode by hand. Compar-
ing the self-reported uptake of identified responders
with participation recorded by the programme, shows
accurate self-reported participation in 98.8% (N =
759) of responders. Similarly, 90.9% (N = 109) of
those who declared that they did not participate had
matching records. The lower accuracy for BSS
non-participants is likely caused by them taking part
after completing the questionnaire. Objective uptake
data were obtained after study participants gave their
permission and sent back the questionnaire to the re-
search team. Relatedly, as a result of the relatively
small proportion of BSS non-attenders, this study
was not powered to properly test the significance
levels of the comparison across barriers by SES or by
non-participant subgroups.
A further limitation is that the study did not assess
the delay between having received the BSS invitation
and answering the questionnaire. Although the ana-
lysis was restricted to responders who indicated that
their age was between 55 and 57 years at the time of
the questionnaire, the length of time period between
receiving BSS invitation and the questionnaire could
have influenced the naming of the participation
barriers.
Our study has strongly implicated pain and embarrass-
ment of the test as common barriers. While this finding
is a useful starting point, there would be value in further
refining exactly what aspects of the test are perceived as
painful and embarrassing, in order to develop potential
strategies to make the test more acceptable. Further-
more, the fact that the combination of both terms was
frequently mentioned, indicates that there might be
some considerable overlap. Understanding the mecha-
nisms behind this relationship might also lead to better
decisions about how to intervene.
Most importantly, future research needs to identify
how to balance the tension between not wanting to
put people off and presenting enough information
about the test to reassure those with strong negative
preconceptions. In addition to written information,
this may well include more facile, flexible and per-
sonal approaches, such as targeted messages, and pa-
tient navigation. Future research could also identify
enabling factors by asking participants more directly
what helped them overcome some of the barriers
that were endorsed by them.
Not needing the test was another frequently men-
tioned barrier by NRs and ADs. Future research
needs to identify the motivation behind citing this
barrier, but it is likely that there is a lack of under-
standing of the unprecedented public health benefit
associated with FS, particularly its ability to prevent
CRC. The UK FS Trial went some way to develop
pictorial information about the adenoma-cancer se-
quence, which was found to significantly increase
knowledge and motivation [22]. Unfortunately, this
approach has not been adopted in the education pro-
vided with the current information leaflet.
Conclusions
This study highlighted that there are important varia-
tions between different types of non-participants in the
bowel scope screening branch of the BCSP. Pain and
embarrassment seem to be important concerns among
those who either never respond or actively decline the
offer. By contrast, people who initially confirm their invi-
tation for bowel scope screening but do not attend their
appointment are more interested and informed, and
tend to come against more specific issues relating to act-
ing on their intention. Interventions to improve uptake
among these different types of non-participants should
be more nuanced and use targeted strategies to improve
uptake. In the short term, this should involve placing
greater emphasis on the perceived benefits of the test as
part of the initial invitation, using additional reminders
for the test and the ability to self-refer, and more flexible
appointment booking systems to reduce the number of
NA’s.
Endnotes
1Due to low numbers we did not stratify combination
of barriers by sub-group.
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